FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Terazosin Hydrochloride Capsules
Status: Discontinuation
»Therapeutic Categories: Cardiovascular; Urology

Expand all

Mylan Pharmaceuticals Inc. (New 06/19/2018)

Company Contact Information:
800-RXMYLAN (1-800-496-9526)

Presentation Posting Date Related Information
1 mg, 100 count bottle (NDC 0378-2260-01) 06/19/2018 The discontinuation of this product is a business decision.
2 mg, 100 count bottle (NDC 0378-2264-01) 06/19/2018 The discontinuation of this product is a business decision.
5 mg, 100 count bottle (NDC 0378-2268-01) 06/19/2018 The discontinuation of this product is a business decision.
10 mg, 100 count bottle (NDC 0378-1570-01) 06/19/2018 The discontinuation of this product is a business decision.

Sandoz (New 06/05/2018)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
Terazosin Hydrochloride Capsules, 1 mg, 100 count bottle (NDC 0781-2051-01, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 1 mg, 500 count bottle (NDC 0781-2051-05, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 2 mg, 100 count bottle (NDC 0781-2052-01, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 2 mg, 500 count bottle (NDC 0781-2052-05, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 5 mg, 100 count bottle (NDC 0781-2053-01, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 5 mg, 500 count bottle (NDC 0781-2053-05, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 10 mg, 100 count bottle (NDC 0781-2054-01, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.
Terazosin Hydrochloride Capsules, 10 mg, 500 count bottle (NDC 0781-2054-05, marketed by Sandoz) 06/05/2018 Sandoz Inc. has made a business decision to permanently discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English